Rd Costs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Singled out in your report, nine of them do something to control the price of prescription drugs. >> but the argument is do they get the same innovation that you get in the united states where you can make a lot of people -- >> well, sure they do. a lot of drug companies are based outside of the united states and they do the innovations outside of the united states. the myth is that they need these high costs to finance research and development. if you look at the math as you always do when you look at companies, you see that their r&d costs are nothing like they say they are. their marketing ...

Iranians want a nuclear weapon, they are going to get one. >> we have seen our last f-22. we -- we have video here. we chased the f-22 and an f-16, years ago, it's a remarkable fighter plane. but good idea to take this -- very expensive? >> very expensive. $150 million to produce. you tie in the r&d costs and it's a very expensive airplane. we have 180 or so. but! remember, the american way of war is premised on air dominance. approximate we don't have the air dominance, the other things don't count. very expensive airplane and the partner is the f-35, the joint strike fighter, less expensive....

Iranians want a nuclear weapon, they are going to get one. >> we have seen our last f-22. we -- we have video here. we chased the f-22 and an f-16, years ago, it's a remarkable fighter plane. but good idea to take this -- very expensive? >> very expensive. $150 million to produce. you tie in the r&d costs and it's a very expensive airplane. we have 180 or so. but! remember, the american way of war is premised on air dominance. approximate we don't have the air dominance, the other things don't count. very expensive airplane and the partner is the f-35, the joint strike fighter, less expensive....

Downturn in the government spending but i agree. we have to be cautious in terms of government spending. we know the austerity measures will have a greater effect going into the year and we're looking at that very, very carefully. but i think it is important also to say that, you know, if you look at the new product areas they grew 15%. >> i was going to say r&d costs up by nearly 20% in the quarter. what will you have to show for that giving encouragement to investors thinking the big dip is a buying opportunity rather than the start of a new trend? >> i mean, for us it is all about innovatio...